Scientists from all three Austrian MedUnis have studied the mortality rate during the Corona pandemic.
A study by all three Austrian MedUnis shows that 17.3 percent of patients died during the first two years of the Corona pandemic.
The Corona pandemic is history. As of June 30, measures still in effect in Austria will fall. Corona is no longer a notifiable disease from that date, “Heute” reported.
Scientists from all three Austrian medical universities have presented a balance sheet for the first two years of the Covid 19 pandemic. In a study published in “Scientific Reports,” they report that 17.3 percent of Covid-19 patients died in Austrian hospitals between January 1, 2020, and December 31, 2021. Men and the very elderly were at extreme risk.
Stays in both regular wards and intensive care units were taken into account. The basis for the study was all available patient data. Overall, men showed a 67 percent higher mortality than women.
“Hospital mortality (of Covid 19 patients; note) was 17.3 percent. The risk factors were male gender (67 percent higher mortality than women; note) and advanced age (a 7.86-fold increase in mortality of over 90-year-olds compared to 60-64-year-olds; note),” explain authors Paul Zajic (MedUni Graz), Michael Hiesmayr (MedUni Vienna) and Michael Joannidis (MedUni Innsbruck).
It is striking that Austrian men were more affected. Of the patients already admitted to intensive care units from the outset (8,304 sufferers), only 35.2 percent were women (2,919 people). 64.8 percent were men (5,385).
The risk of death also increases with age. While Covid 19 patients aged up to 19 years after hospital admission had only five percent of the risk of dying of 60- to 64-year-old sufferers, and 55- to 59-year-olds were at about half the risk (55 percent) of the comparison group, the risk already increased by 42 percent among 65- to 69-year-olds.
The data show that one by injection – in case of need and by fast application of medicines such as Paxlovid etc. – should try to prevent SARS-Co. – should be used to protect those infected with SARS-CoV-2 from severe disease courses.
- source: heute.at/picture: pixabay.com
This post has already been read 1262 times!